DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vivaglobin (Immune Globulin Subcutaneous Human) - Thrombocytopenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Thrombocytopenia (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vivaglobin (Immune Globulin Subcutaneous Human) where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vivaglobin side effects in 51 year old male

Reported by a physician from France on 2012-03-30

Patient: 51 year old male

Reactions: Diabetes Mellitus, Anaemia, Cytomegalovirus Infection, Toxicity To Various Agents, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
ACT HIB (Haemophilus B Conjugate Vaccine)
    Indication: Immunisation
    Start date: 2011-09-26
    End date: 2011-09-26

ACT HIB (Haemophilus B Conjugate Vaccine)
    Indication: Immunisation
    Start date: 2011-11-08
    End date: 2011-11-08

Noxafil
    Dosage: 200 mg;tid
    Indication: Oral Lichen Planus
    Start date: 2011-07-15
    End date: 2011-09-26

Vivaglobin
    Dosage: 1 df;qw;iv
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-25

Ganciclovir
    Dosage: 250 mg;qd;po
    Administration route: Oral
    Indication: Cytomegalovirus Viraemia
    Start date: 2011-08-12
    End date: 2011-08-26

Ganciclovir
    Dosage: 250 mg;qd;po
    Administration route: Oral
    Indication: Cytomegalovirus Viraemia
    Start date: 2011-07-15
    End date: 2011-07-20

Prednisone
    Dosage: 30 mg;bid
    Indication: Acute Graft Versus Host Disease
    Start date: 2011-07-15
    End date: 2011-09-26

Other drugs received by patient: Foscavir



Possible Vivaglobin side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-27

Patient: 51 year old male

Reactions: Polydipsia, Incorrect Route of Drug Administration, Graft Versus Host Disease, Cytomegalovirus Test Positive, Diabetes Mellitus, Polyuria, Off Label Use, Bone Marrow Disorder, Haemoglobin Decreased, Thrombocytopenia, Leukopenia, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin
    Dosage: 6.4 g 1x/week, 160mg/ml every 7 days intravenous (not otherwise specified)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-25

Noxafil
    Start date: 2011-07-15
    End date: 2011-09-26

ACT HIB (Haemophilus B Conjugate Vaccine)
    Indication: Immunisation
    Start date: 2011-09-26
    End date: 2011-09-26

ACT HIB (Haemophilus B Conjugate Vaccine)
    Indication: Immunisation
    Start date: 2011-11-08
    End date: 2011-11-08

Other drugs received by patient: Foscavir; Prednisone TAB; Ganciclovir



Possible Vivaglobin side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-05

Patient: 51 year old male

Reactions: Incorrect Route of Drug Administration, White Blood Cell Count Decreased, Polydipsia, Graft Versus Host Disease, Cytomegalovirus Test Positive, Polyuria, Haemoglobin Decreased, Bone Marrow Disorder, Off Label Use, Thrombocytopenia, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin

Other drugs received by patient: Ganciclovir; Voriconazole; Prednisone TAB; ACT HIB (Haemophilus B Conjugate Vaccine)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017